Masimo Revenue 2007-2019 | MASI
Masimo annual/quarterly revenue history and growth rate from 2007 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Masimo revenue for the quarter ending March 31, 2019 was $0.232B, a 8.79% increase year-over-year.
- Masimo revenue for the twelve months ending March 31, 2019 was $877M, a 8.73% increase year-over-year.
- Masimo annual revenue for 2018 was $0.858B, a 8.61% increase from 2017.
- Masimo annual revenue for 2017 was $0.79B, a 10.85% increase from 2016.
- Masimo annual revenue for 2016 was $0.713B, a 13.14% increase from 2015.
| Masimo Annual Revenue (Millions of US $) |
|
|---|---|
| 2018 | $858 |
| 2017 | $790 |
| 2016 | $713 |
| 2015 | $630 |
| 2014 | $587 |
| 2013 | $547 |
| 2012 | $493 |
| 2011 | $439 |
| 2010 | $405 |
| 2009 | $349 |
| 2008 | $307 |
| 2007 | $256 |
| 2006 | $224 |
| 2005 | $108 |
| Masimo Quarterly Revenue (Millions of US $) |
|
|---|---|
| Q1 2019 | $232 |
| Q4 2018 | $223 |
| Q3 2018 | $211 |
| Q2 2018 | $212 |
| Q1 2018 | $213 |
| Q4 2017 | $208 |
| Q3 2017 | $193 |
| Q2 2017 | $192 |
| Q1 2017 | $197 |
| Q4 2016 | $201 |
| Q3 2016 | $168 |
| Q2 2016 | $173 |
| Q1 2016 | $171 |
| Q4 2015 | $167 |
| Q3 2015 | $153 |
| Q2 2015 | $156 |
| Q1 2015 | $155 |
| Q4 2014 | $162 |
| Q3 2014 | $144 |
| Q2 2014 | $141 |
| Q1 2014 | $140 |
| Q4 2013 | $142 |
| Q3 2013 | $131 |
| Q2 2013 | $137 |
| Q1 2013 | $136 |
| Q4 2012 | $132 |
| Q3 2012 | $119 |
| Q2 2012 | $123 |
| Q1 2012 | $119 |
| Q4 2011 | $112 |
| Q3 2011 | $104 |
| Q2 2011 | $110 |
| Q1 2011 | $113 |
| Q4 2010 | $106 |
| Q3 2010 | $101 |
| Q2 2010 | $100 |
| Q1 2010 | $99 |
| Q4 2009 | $93 |
| Q3 2009 | $87 |
| Q2 2009 | $84 |
| Q1 2009 | $85 |
| Q4 2008 | $83 |
| Q3 2008 | $78 |
| Q2 2008 | $75 |
| Q1 2008 | $71 |
| Q4 2007 | $69 |
| Q3 2007 | $64 |
| Q2 2007 | $64 |
| Q1 2007 | $59 |
| Q3 2006 | $58 |
| Q2 2006 | $56 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.525B | $0.858B |
| Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $114.099B | 24.96 |
| Intuitive Surgical (ISRG) | United States | $57.325B | 52.82 |
| Edwards Lifesciences (EW) | United States | $38.350B | 38.32 |
| IDEXX Laboratories (IDXX) | United States | $23.038B | 60.44 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $22.958B | 15.08 |
| Teleflex (TFX) | United States | $14.780B | 32.02 |
| DexCom (DXCM) | United States | $13.479B | 264.36 |
| Hologic (HOLX) | United States | $12.824B | 20.62 |
| Varian Medical Systems (VAR) | United States | $11.903B | 30.37 |
| STERIS (STE) | Ireland | $11.874B | 28.72 |
| ABIOMED (ABMD) | United States | $11.325B | 69.13 |
| Penumbra (PEN) | United States | $5.795B | 245.34 |
| Integra LifeSciences Holdings (IART) | United States | $4.349B | 20.43 |
| Globus Medical (GMED) | United States | $4.078B | 25.43 |
| Wright Medical Group (WMGI) | Netherlands | $3.945B | 782.00 |
| Tandem Diabetes Care (TNDM) | United States | $3.692B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.548B | 23.13 |
| Cantel Medical (CMD) | United States | $3.187B | 32.33 |
| Glaukos (GKOS) | United States | $2.669B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.549B | 18.79 |
| AVANOS MEDICAL, INC (AVNS) | United States | $2.054B | 32.51 |
| Nevro (NVRO) | United States | $1.920B | 0.00 |
| ShockWave Medical (SWAV) | United States | $1.630B | 0.00 |
| Inogen (INGN) | United States | $1.491B | 33.01 |
| Silk Road Medical (SILK) | United States | $1.380B | 0.00 |
| OPKO Health (OPK) | United States | $1.170B | 0.00 |
| Veracyte (VCYT) | United States | $1.148B | 0.00 |
| CryoLife (CRY) | United States | $1.087B | 107.85 |
| Accelerate Diagnostics (AXDX) | United States | $1.075B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.015B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.003B | 147.97 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.979B | 28.36 |
| Luminex (LMNX) | United States | $0.958B | 125.35 |
| ViewRay (VRAY) | United States | $0.848B | 0.00 |
| Fluidigm (FLDM) | United States | $0.845B | 0.00 |
| Natus Medical (BABY) | United States | $0.815B | 18.87 |
| Mesa Laboratories (MLAB) | United States | $0.790B | 37.14 |
| AxoGen (AXGN) | United States | $0.789B | 0.00 |
| Intersect ENT (XENT) | United States | $0.766B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.726B | 25.32 |
| OrthoPediatrics (KIDS) | United States | $0.589B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.567B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.566B | 0.00 |
| Si-Bone (SIBN) | United States | $0.429B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.386B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.375B | 20.10 |
| Accuray (ARAY) | United States | $0.327B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.310B | 38.18 |
| ConforMIS (CFMS) | United States | $0.309B | 0.00 |
| TransEnterix (TRXC) | United States | $0.287B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.256B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.255B | 0.00 |
| IRadimed (IRMD) | United States | $0.223B | 42.57 |
| Alphatec Holdings (ATEC) | United States | $0.221B | 0.00 |
| Soliton (SOLY) | United States | $0.214B | 0.00 |
| Neuronetics (STIM) | United States | $0.212B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.204B | 71.25 |
| Sientra (SIEN) | United States | $0.189B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.166B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.097B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.088B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.083B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.078B | 0.00 |
| Vermillion (VRML) | United States | $0.077B | 0.00 |
| EDAP TMS (EDAP) | France | $0.075B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.068B | 0.00 |
| Nuvectra (NVTR) | United States | $0.066B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.062B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.047B | 0.00 |
| Electromed (ELMD) | United States | $0.045B | 23.04 |
| Ra Medical Systems (RMED) | United States | $0.043B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.039B | 0.00 |
| Neovasc (NVCN) | Canada | $0.036B | 0.00 |
| PAVmed (PAVM) | United States | $0.036B | 0.00 |
| Avinger (AVGR) | United States | $0.029B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.025B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.022B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.021B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.021B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.020B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.019B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.017B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.017B | 18.13 |
| OBALON THERPTCS (OBLN) | United States | $0.016B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.016B | 0.00 |
| Dynatronics (DYNT) | United States | $0.012B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.011B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.007B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.007B | 0.00 |
| InspireMD (NSPR) | Israel | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
| ALCON INC (ALC) | $0.000B | 0.00 |
